APhA Statement Following Emergency Use Authorization of the Moderna COVID-19 Vaccine
Statement from Scott J. Knoer, MS, PharmD, FASHP, executive vice president and CEO of the American Pharmacists Association, upon the Food and Drug Administration's (...
Dec 19